What We're Reading: Page 13
Industry reads hand-picked by our editors
May 02, 2025
-
Fierce Biotech
FDA lifts hold on Amgen’s phase 1 obesity study
-
FirstWord Pharma
BMS to close Illinois site as part of cell therapy manufacturing consolidation
-
MIT Technology Review
The US has approved CRISPR pigs for food
May 01, 2025
-
Bloomberg
Pfizer Eyes Smaller Drugmakers After Failure of Obesity Pill
-
Chemical & Engineering News
FDA’s shift from animal testing opens doors for organoid makers
-
ApexOnco
AACR 2025 – a requiem for Roche’s TIGIT
-
The Economist
Rates of bowel cancer are rising among young people
Apr 30, 2025
-
The Wall Street Journal
Drugmakers Have Spent Millions Targeting ‘Middlemen’—and It’s Paying Off
-
The New York Times
Kennedy Advises New Parents to ‘Do Your Own Research’ on Vaccines
-
CBS News
FDA to undo some layoffs, after cuts to inspections and drug safety
Apr 29, 2025
-
Inside Medicine
In conversation with FDA Commissioner Dr. Marty Makary.
-
Manufacturing Dive
Regeneron expands US manufacturing with $3B Fujifilm partnership
-
MedTech Dive
Trump’s tariff effect has dominated medtech earnings calls
Previous
